CancerIQ closes $14M funding round

2020 02 27 23 28 4046 Doctor Cancer Patient 400

Oncology software developer CancerIQ recently closed a $14 million financing round that will go toward developing the company's applications for improving access to innovations in early cancer detection and prevention.

The funding round was co-led by Merck Global Health Innovation Fund and Amgen Ventures. McKesson Ventures, OSF Ventures, and HealthX Ventures also participated.

CancerIQ said the new funding will help the company grow its precision health platform, strengthen its partnership ecosystem, and expand its health system network. It also plans to hire 50 team members in the near future. The company made executive hires in January.

The company is developing software that helps healthcare providers detect and prevent cancer at an earlier stage. The company's software can be integrated directly into electronic health records, making it easier to gather patient data and map it to evidence-based guidelines, while also expanding access to personalized care plans and new clinical treatments.

Page 1 of 7
Next Page